Rinexin (Phenylpropanolamine)
Oral nasal decongestant – Extended-release tablet 50 mg
Rinexin is a prescription oral decongestant containing phenylpropanolamine hydrochloride 50 mg in an extended-release tablet formulation. It is used to relieve nasal congestion and stuffiness caused by allergic rhinitis or vasomotor rhinitis. Unlike topical nasal sprays, Rinexin works systemically to reach areas of the nasal mucosa that cannot be accessed by local treatment. The extended-release formulation provides sustained relief with twice-daily dosing.
Quick Facts
Key Takeaways
- Rinexin contains phenylpropanolamine 50 mg in an extended-release tablet that provides sustained nasal decongestion with morning and evening dosing.
- The tablet must be swallowed whole — never crushed, chewed, or split — to maintain its extended-release properties.
- Contraindicated in patients with hyperthyroidism, pheochromocytoma, or allergy to the active ingredient.
- Common side effects include nervousness, insomnia, dry mouth, and urinary difficulty in men with prostatic hyperplasia.
- Rinexin can enhance the effects of caffeine — consider reducing coffee and tea intake during treatment.
What Is Rinexin and What Is It Used For?
Rinexin belongs to a class of medications known as sympathomimetic amines, which act on the sympathetic nervous system to produce a decongestant effect in the nasal passages. The active ingredient, phenylpropanolamine (PPA), is an alpha-adrenergic agonist that works by constricting the dilated blood vessels in the nasal mucosa. This vasoconstriction reduces the swelling of the mucosal lining, thereby improving nasal airflow and relieving the sensation of stuffiness.
One of the key advantages of Rinexin over topical nasal decongestants (such as oxymetazoline or xylometazoline sprays) is its systemic mode of action. Because phenylpropanolamine is absorbed through the gastrointestinal tract and distributed via the bloodstream, it can reach areas of the nasal mucosa that topical sprays and drops cannot effectively access. This is particularly beneficial for patients with deep-seated mucosal congestion or those who have difficulty using nasal sprays.
The extended-release formulation of Rinexin is designed as a coated tablet consisting of a core surrounded by an outer layer. Both the core and the outer layer contain the active ingredient. When taken, a portion of phenylpropanolamine is released immediately from the outer layer, providing rapid onset of decongestion. The remaining medication is then slowly released from the core over several hours, ensuring a sustained therapeutic effect. This dual-release mechanism means that satisfactory symptom relief can be achieved throughout the day and night with just one tablet in the morning and one in the evening.
Rinexin is indicated for two primary conditions: allergic rhinitis, where nasal congestion results from an immune-mediated response to allergens such as pollen, dust mites, or pet dander; and vasomotor rhinitis, a condition characterized by chronic nasal congestion due to abnormal dilation of blood vessels in the nasal mucosa, often triggered by changes in temperature, humidity, or other non-allergic factors. In both conditions, the underlying problem is excessive swelling of the nasal tissues, which Rinexin effectively addresses through its vasoconstrictive action.
Phenylpropanolamine (PPA) has been the subject of regulatory review in several countries. In 2000, the FDA requested voluntary withdrawal of PPA-containing products in the United States due to a potential association with hemorrhagic stroke, particularly in women using PPA as an appetite suppressant at higher doses. However, PPA remains available by prescription in several European countries at decongestant doses (50 mg). The risk-benefit profile differs between decongestant use and appetite suppressant use, and your prescribing physician has determined that the benefits outweigh the risks for your specific condition. Always follow your doctor's instructions carefully.
What Should You Know Before Taking Rinexin?
Contraindications
There are specific situations in which Rinexin must not be used. These absolute contraindications exist because the pharmacological effects of phenylpropanolamine could cause serious or life-threatening complications in patients with certain medical conditions:
- Allergy to phenylpropanolamine hydrochloride or any of the other ingredients in the tablet (see the Ingredients section below). An allergic reaction may manifest as skin rash, swelling, or difficulty breathing.
- Hyperthyroidism (overactive thyroid gland) — Phenylpropanolamine's sympathomimetic effects can exacerbate the cardiovascular manifestations of thyrotoxicosis, including tachycardia, hypertension, and cardiac arrhythmias.
- Pheochromocytoma — This rare adrenal gland tumor produces excessive catecholamines. Adding a sympathomimetic agent such as phenylpropanolamine can trigger a hypertensive crisis with potentially fatal consequences.
Warnings and Precautions
Speak with your doctor or pharmacist before taking Rinexin if you have any of the following conditions, as the medication may need to be used with particular caution or at a reduced dose:
- Diabetes mellitus — Sympathomimetic agents can affect blood glucose levels. Patients with diabetes should monitor their blood sugar more frequently when starting Rinexin and report any significant changes to their healthcare provider.
- Bladder neck obstruction or pyloric stenosis — Phenylpropanolamine's alpha-adrenergic effects can worsen urinary retention in patients with mechanical obstruction at the bladder neck or lower stomach outlet.
- Impaired kidney function (renal insufficiency) — Reduced kidney function may affect the elimination of the drug, potentially leading to accumulation and increased risk of adverse effects. Dose adjustment may be necessary.
- Benign prostatic hyperplasia (enlarged prostate) — Men with an enlarged prostate are at increased risk of urinary retention when taking sympathomimetic medications. Rinexin may worsen difficulty urinating in these patients.
- Hypertension or other cardiovascular disease — Phenylpropanolamine can raise blood pressure and heart rate. Patients with pre-existing hypertension, coronary artery disease, heart failure, or arrhythmias require careful monitoring during treatment.
Rinexin can cause dry mouth (xerostomia) as a side effect. Reduced saliva flow increases the risk of dental caries, oral candidiasis, and other oral health problems. It is therefore important to maintain thorough oral hygiene during treatment, including regular brushing, flossing, and staying well hydrated. Consider using sugar-free gum or saliva substitutes if dry mouth persists.
Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before taking Rinexin. The safety of phenylpropanolamine during pregnancy has not been fully established in controlled clinical trials.
Pregnancy: As a precautionary measure, Rinexin should be avoided during pregnancy. Sympathomimetic agents may potentially affect uterine blood flow and fetal heart rate. The decision to use Rinexin during pregnancy should be made only by a physician who has carefully weighed the potential benefits against the possible risks to both mother and fetus.
Breastfeeding: Phenylpropanolamine passes into breast milk, but at therapeutic doses it is unlikely to affect the nursing infant. However, consult your doctor before using Rinexin for more than occasional use during breastfeeding, as accumulation could theoretically occur with prolonged or frequent dosing. Monitor the infant for signs of irritability, poor feeding, or sleep disturbance.
Driving and Operating Machinery
Rinexin has no known effect on the ability to drive or operate machinery at recommended doses. However, individual responses may vary, and some patients may experience nervousness or insomnia that could indirectly affect alertness. If you experience any side effects that impair your concentration or reaction time, avoid driving or operating heavy machinery until these effects have resolved.
Lactose Content
Rinexin contains lactose monohydrate (230 mg per tablet) as an excipient. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Rinexin.
How Does Rinexin Interact with Other Drugs?
Drug interactions occur when one medication affects the way another medication works, potentially altering its effectiveness or increasing the risk of side effects. Because phenylpropanolamine acts on the sympathetic nervous system, it can interact with a range of other drugs that affect cardiovascular function, blood pressure regulation, or adrenergic signaling.
Major Interactions
| Drug / Class | Effect of Interaction | Recommendation |
|---|---|---|
| MAO inhibitors (e.g., phenelzine, tranylcypromine, moclobemide) | Severe, potentially life-threatening hypertensive crisis due to potentiated sympathomimetic effects | Contraindicated. Do not use Rinexin within 14 days of MAO inhibitor therapy. |
| Other sympathomimetics (e.g., pseudoephedrine, phenylephrine, amphetamines) | Additive cardiovascular stimulation: increased blood pressure, tachycardia, risk of arrhythmia | Avoid concurrent use. Check OTC cold remedies for hidden sympathomimetics. |
| Tricyclic antidepressants (e.g., amitriptyline, nortriptyline) | Enhanced pressor response to phenylpropanolamine; increased risk of hypertension and arrhythmia | Use with caution. Monitor blood pressure closely. |
Minor Interactions
| Drug / Class | Effect of Interaction | Recommendation |
|---|---|---|
| Beta-blockers (e.g., propranolol, atenolol) | Unopposed alpha-adrenergic stimulation may lead to paradoxical hypertension | Monitor blood pressure. Non-selective beta-blockers carry higher risk. |
| Antihypertensives (e.g., ACE inhibitors, ARBs, calcium channel blockers) | Reduced antihypertensive efficacy due to the pressor effects of phenylpropanolamine | Monitor blood pressure. Dose adjustment of antihypertensive may be needed. |
| Caffeine (coffee, tea, energy drinks, caffeine tablets) | Enhanced stimulant effects: nervousness, insomnia, tachycardia, blood pressure elevation | Reduce caffeine intake. Avoid large amounts of caffeinated beverages. |
| Indomethacin and other NSAIDs | NSAIDs may increase the pressor effect of sympathomimetics; potential for blood pressure elevation | Use with caution. Monitor blood pressure if used concurrently. |
This list is not exhaustive. Always inform your doctor or pharmacist about all medications you are currently taking, have recently taken, or might take, including prescription drugs, over-the-counter medicines, herbal supplements, and vitamins. Pay particular attention to combination cold and flu products, as these frequently contain sympathomimetic decongestants that could interact with Rinexin.
What Is the Correct Dosage of Rinexin?
Always take Rinexin exactly as your doctor or pharmacist has told you. Do not change the dose or stop taking the medication without consulting your healthcare provider first. The dose should be individually adjusted by your prescribing physician based on your specific condition and response to treatment.
Adults and Children Over 12 Years
Standard Dose
1 extended-release tablet (50 mg) in the morning and 1 tablet (50 mg) in the evening.
Take the tablets at approximately the same times each day, ideally 12 hours apart, to maintain consistent blood levels of the medication throughout the 24-hour period.
Children Under 12 Years
Pediatric Use
Rinexin is not recommended for children under 12 years of age. The safety and efficacy of phenylpropanolamine extended-release tablets have not been established in this age group. For nasal congestion in younger children, consult your pediatrician for age-appropriate alternatives.
Elderly Patients
Dose Considerations
Elderly patients may be more susceptible to the cardiovascular effects of sympathomimetic agents, including blood pressure elevation and urinary retention (particularly men with benign prostatic hyperplasia). Your doctor may start with a lower dose or monitor you more closely. Report any urinary difficulties, rapid heartbeat, or dizziness promptly.
How to Take the Tablet
Rinexin is a specially designed coated tablet (mantle tablet) consisting of an inner core surrounded by an outer layer. Both the core and the outer layer contain the active ingredient phenylpropanolamine. This unique design provides the extended-release mechanism:
- Outer layer: A portion of the active ingredient is released immediately upon ingestion, providing rapid onset of decongestant effect.
- Inner core: The remaining active ingredient is released slowly over several hours from the core, maintaining therapeutic levels throughout the dosing interval.
The tablet must be swallowed whole with a glass of water. Breaking, crushing, or chewing the tablet destroys the extended-release mechanism, causing the entire dose to be released at once. This could lead to an excessive peak concentration of the drug, increasing the risk of serious side effects including sudden blood pressure elevation, severe headache, and cardiac arrhythmias.
Missed Dose
If you forget to take a dose of Rinexin, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one, as this could increase the risk of side effects.
Overdose
If you have taken more Rinexin than prescribed, or if a child has accidentally ingested the medication, contact your doctor, hospital emergency department, or poison control center immediately for risk assessment and advice.
Symptoms of overdose may include:
- Agitation and restlessness
- Aggression or unusual behavior
- Depressive thoughts
- Drowsiness or excessive tiredness
- Dilated pupils (mydriasis)
- Severe headache
- Dizziness and blurred vision
- Nausea and vomiting
- Tremors
- Heart rhythm disturbances (arrhythmias)
- Significant blood pressure changes (hypertension or hypotension)
In case of suspected overdose, do not wait for symptoms to appear. Seek immediate medical attention. Overdose with sympathomimetic agents can be life-threatening due to the risk of hypertensive crisis, intracranial hemorrhage, and cardiac arrhythmias. Bring the medication packaging with you to the emergency department.
What Are the Side Effects of Rinexin?
Side effects are classified below according to their frequency of occurrence. Understanding these categories helps you assess the likelihood of experiencing each side effect. If you experience any side effects, including ones not listed here, talk to your doctor or pharmacist. You can also report side effects directly to your national pharmacovigilance authority.
Common
May affect up to 1 in 10 users
- Nervousness and insomnia — Due to the stimulant properties of phenylpropanolamine on the central nervous system. Taking the evening dose earlier may help reduce sleep disturbance.
- Dry mouth and nasal dryness — Caused by reduced secretory activity in the mucous membranes. Maintain thorough oral hygiene and stay well hydrated.
- Urinary difficulty — Especially in older men with benign prostatic hyperplasia (enlarged prostate). The alpha-adrenergic effect can increase smooth muscle tone in the bladder neck, making urination more difficult.
Uncommon
May affect up to 1 in 100 users
- Hypersensitivity reactions — Skin rash, itching (pruritus), or urticaria. Discontinue Rinexin and consult your doctor if you develop signs of an allergic reaction.
Rare
May affect up to 1 in 1,000 users
- Transient blood pressure elevation — Usually mild and self-limiting, but may be clinically significant in patients with pre-existing hypertension.
- Hallucinations (delusions) — Unusual perceptual disturbances that resolve upon discontinuation of the medication.
- Confusion — Particularly in elderly patients. Mental disorientation or difficulty with coherent thought processes.
- Nightmares — Vivid, disturbing dreams that may disrupt sleep quality.
- Aggression — Unusual irritability or aggressive behavior. Discontinue and consult your doctor.
Very Rare
May affect up to 1 in 10,000 users
- Cerebral hemorrhage (brain bleeding) — An extremely rare but serious adverse event. Seek immediate emergency medical attention if you experience sudden severe headache, vision changes, one-sided weakness, speech difficulties, or altered consciousness.
Frequency Not Known
Cannot be estimated from available data
- Tremor — Involuntary shaking, usually of the hands, due to sympathomimetic stimulation.
- Palpitations — A noticeable awareness of the heartbeat, which may be rapid or irregular. Consult your doctor if palpitations are persistent or accompanied by chest pain.
Contact emergency services or go to the nearest emergency department immediately if you experience: sudden severe headache, chest pain, difficulty breathing, one-sided weakness or numbness, speech problems, vision changes, or signs of a severe allergic reaction (swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing).
Reporting Side Effects
Reporting suspected adverse reactions after marketing authorization is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority. In the United States, report to the FDA MedWatch program. In the European Union, report through your national competent authority. In the United Kingdom, report via the Yellow Card Scheme.
How Should You Store Rinexin?
Proper storage of medications is essential to ensure that they remain effective and safe throughout their shelf life. Improper storage can lead to degradation of the active ingredient, potentially reducing efficacy or producing harmful breakdown products.
| Pack Type | Pack Sizes | Storage Conditions |
|---|---|---|
| Blister pack | 30 or 60 tablets | Store below 25°C. Protect from moisture. |
| Plastic bottle | 100 tablets | No special storage requirements. Keep the lid tightly closed. |
Expiry date: Do not use Rinexin after the expiry date printed on the packaging (after “EXP”). The expiry date refers to the last day of the month indicated.
General precautions: Keep all medicines out of the sight and reach of children. Store in the original packaging to protect from light and moisture. Do not transfer tablets to a different container unless it provides equivalent protection.
Disposal: Do not dispose of medicines via wastewater or household waste. Return unused or expired medicines to your local pharmacy for safe disposal. These measures help protect the environment by preventing pharmaceutical contamination of water supplies and soil.
What Does Rinexin Contain?
Active substance: Phenylpropanolamine hydrochloride 50 mg per extended-release tablet.
Excipients (inactive ingredients):
- Lactose monohydrate (230 mg)
- Maize starch (corn starch)
- Medium-chain triglycerides
- Tristearin
- Talc
- Gelatin
- Glycerol
- Magnesium stearate
- Polyvinylpyrrolidone-vinyl acetate copolymer
- Anhydrous citric acid
Appearance: White, convex, film-coated tablets with a diameter of 10 mm.
Available pack sizes: 30 and 60 tablets (blister packs), 100 tablets (plastic bottle). Not all pack sizes may be marketed in your country.
Marketing authorization holder: Viatris AB, Stockholm, Sweden.
Manufacturer: Delpharm L'Aigle, Zone Industrielle N° 1, Route de Crulai, L'Aigle 61300, France.
Frequently Asked Questions About Rinexin
Rinexin is an oral (systemic) decongestant, meaning it works throughout the body via the bloodstream, while nasal sprays like oxymetazoline or xylometazoline act locally on the nasal mucosa. The key advantage of Rinexin is that it can reach deeper areas of the nasal passages that sprays cannot effectively access. Additionally, Rinexin's extended-release formulation provides sustained 12-hour relief per dose, whereas most nasal sprays need more frequent application. However, nasal sprays generally have fewer systemic side effects since they act locally. Your doctor will recommend the most appropriate option based on your specific condition.
You should be cautious with caffeine while taking Rinexin. Phenylpropanolamine can enhance the effects and side effects of caffeine, including increased nervousness, restlessness, elevated heart rate, and blood pressure. This applies to all caffeine-containing beverages including coffee, tea, cola drinks, and energy drinks. It is advisable to reduce your caffeine intake during treatment. If you regularly consume large amounts of caffeine, discuss this with your doctor.
The duration of treatment with Rinexin should be determined by your doctor based on your individual condition. For acute nasal congestion due to seasonal allergies, short-term use may be sufficient. For chronic conditions such as perennial allergic rhinitis or vasomotor rhinitis, longer treatment periods may be appropriate. However, oral decongestants are generally intended for short-to-medium-term use. If your symptoms persist or worsen despite treatment, consult your doctor for reassessment. Do not exceed the prescribed duration of treatment without medical advice.
Elderly patients may be more sensitive to the effects of Rinexin, particularly cardiovascular effects (blood pressure elevation, heart rate changes) and urinary retention (especially men with enlarged prostate). While Rinexin is not contraindicated in the elderly, it should be used with caution and under closer medical supervision. Your doctor may recommend a lower dose or more frequent monitoring of blood pressure and urinary function. Report any new symptoms promptly, including difficulty urinating, dizziness, confusion, or palpitations.
If you accidentally crush or chew a Rinexin tablet, the entire 50 mg dose will be released at once instead of gradually over several hours. This may cause a higher peak blood level of phenylpropanolamine than intended. Monitor yourself for signs of excessive stimulation such as headache, rapid heartbeat, nervousness, or elevated blood pressure. If you experience any concerning symptoms, contact your doctor or pharmacist for advice. For your next dose, take the tablet whole as directed. If you have difficulty swallowing tablets, speak with your doctor about alternative treatment options.
The combination of Rinexin with antihistamines is often used in clinical practice, as decongestants and antihistamines address different aspects of allergic rhinitis — Rinexin reduces nasal congestion while antihistamines reduce sneezing, itching, and runny nose. However, some older (first-generation) antihistamines may have additive side effects such as dry mouth and urinary retention. Always consult your doctor before combining medications, and inform them of all medicines you are taking, including over-the-counter antihistamines.
References
This article is based on the following evidence-based sources and international medical guidelines:
- European Medicines Agency (EMA). Summary of Product Characteristics: Phenylpropanolamine-containing medicinal products. EMA Regulatory Documentation. 2024.
- World Health Organization (WHO). WHO Model List of Essential Medicines, 23rd List. Geneva: WHO; 2023.
- Eccles R. Substitution of phenylephrine for pseudoephedrine as a nasal decongestant. An illogical way to control methamphetamine abuse. British Journal of Clinical Pharmacology. 2007;63(1):10-14.
- Hatton RC, Winterstein AG, McKelvey RP, Shuster J, Hendeles L. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Annals of Pharmacotherapy. 2007;41(3):381-390.
- FDA Drug Safety Communication. Phenylpropanolamine Advisory Committee. U.S. Food and Drug Administration. 2005.
- British National Formulary (BNF). Sympathomimetics, vasoconstrictor — Systemic nasal decongestants. NICE Evidence Services. 2025.
- Pray WS. Nonprescription Product Therapeutics. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. Chapter on Nasal Congestion.
- Scolaro KL. Disorders Related to Cold and Allergy. In: Krinsky DL, et al., eds. Handbook of Nonprescription Drugs. 20th ed. Washington, DC: APhA; 2021.
- Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. New England Journal of Medicine. 2000;343(25):1826-1832.
- Lake CR, Gallant S, Masson E, Miller P. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. American Journal of Medicine. 1990;89(2):195-208.
Editorial Team
This article has been written and reviewed by iMedic's medical editorial team, which includes specialists in clinical pharmacology, otorhinolaryngology, and internal medicine.
iMedic Medical Editorial Team — licensed physicians with expertise in pharmacology and evidence-based medicine.
iMedic Medical Review Board — independent panel of medical specialists who verify accuracy, completeness, and adherence to international guidelines.
Editorial standards: All content follows the iMedic Editorial Standards, based on the GRADE evidence framework. We maintain strict independence from pharmaceutical companies and accept no commercial funding.
Last fact-checked: